Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01795456 · ClinicalTrials.gov registry record
Carotid Artery Neovascularization in Takayasu's and Giant Cell Arteritis
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 7
- Enrollment target
NCT01795456: Completed study, sponsored by The Cleveland Clinic.
NCT01795456 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01795456 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the ability of contrast enhanced carotid ultrasound to serve as an indicator of disease activity in patients with Takayasu's arteritis or Giant Cell arteritis and to determine if patients with active arteritis have a thickening of their blood vessel walls compared to healthy people of the same age and gender.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2010-08 |
| Est. Completion | 2014-01 |
What the finished NCT01795456 record still lists
NCT01795456 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01795456 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01795456 about?
NCT01795456 is a clinical study titled "Carotid Artery Neovascularization in Takayasu's and Giant Cell Arteritis". The purpose of this study is to evaluate the ability of contrast enhanced carotid ultrasound to serve as an indicator of disease activity in patients with Takayasu's arteritis or Giant Cell arteritis and to determine if patients with active arteritis have a thickening of their blood vessel walls com...
What is the current status of trial NCT01795456?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2010-08. Estimated completion is 2014-01.
Who is sponsoring clinical trial NCT01795456?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia